Nivolumab versus chemotherapy in advanced esophageal squamous cell carcinoma (ESCC): The phase III ATTRACTION-3 study

B. C. Cho; K. Kato; M. Takahashi; M. Okada; C-Y. Lin; K. Chin; S. Kadowaki; M-J. Ahn; Y. Hamamoto; Y. Doki; C-C. Yen; Y. Kubota; S-B. Kim; C-H. Hsu; E. Holtved; I. Xynos; M. Kodani; Y. Kitagawa

doi:10.1093/annonc/mdz394.028

Nivolumab versus chemotherapy in advanced esophageal squamous cell carcinoma (ESCC): The phase III ATTRACTION-3 study

B. C. Cho, K. Kato, M. Takahashi, M. Okada, C-Y. Lin, K. Chin, S. Kadowaki, M-J. Ahn, Y. Hamamoto, Y. Doki, C-C. Yen, Y. Kubota, S-B. Kim, C-H. Hsu, E. Holtved, I. Xynos, M. Kodani, Y. Kitagawa

KI, OUH, Forskningsenhed for Onkologi (Odense)

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	LBA11
Tidsskrift	Annals of Oncology
Vol/bind	30
Udgave nummer	Suppl. 5
Sider (fra-til)	873-874
ISSN	0923-7534
DOI	https://doi.org/10.1093/annonc/mdz394.028
Status	Udgivet - okt. 2019
Begivenhed	44th Congress of the European Society for Medical Oncology - Barcelona, Spanien Varighed: 27. sep. 2019 → 1. okt. 2019

Konference

Konference	44th Congress of the European Society for Medical Oncology
Land/Område	Spanien
By	Barcelona
Periode	27/09/2019 → 01/10/2019

Dokumenter og links

10.1093/annonc/mdz394.028

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Cho, B. C., Kato, K., Takahashi, M., Okada, M., Lin, C.-Y., Chin, K., Kadowaki, S., Ahn, M.-J., Hamamoto, Y., Doki, Y., Yen, C.-C., Kubota, Y., Kim, S.-B., Hsu, C.-H., Holtved, E., Xynos, I., Kodani, M., & Kitagawa, Y. (2019). Nivolumab versus chemotherapy in advanced esophageal squamous cell carcinoma (ESCC): The phase III ATTRACTION-3 study. Annals of Oncology, 30(Suppl. 5), 873-874. Artikel LBA11. https://doi.org/10.1093/annonc/mdz394.028

@article{d4a7dc5cc308447d896c571bfddebfc6,

title = "Nivolumab versus chemotherapy in advanced esophageal squamous cell carcinoma (ESCC): The phase III ATTRACTION-3 study",

author = "Cho, {B. C.} and K. Kato and M. Takahashi and M. Okada and C-Y. Lin and K. Chin and S. Kadowaki and M-J. Ahn and Y. Hamamoto and Y. Doki and C-C. Yen and Y. Kubota and S-B. Kim and C-H. Hsu and E. Holtved and I. Xynos and M. Kodani and Y. Kitagawa",

year = "2019",

month = oct,

doi = "10.1093/annonc/mdz394.028",

language = "English",

volume = "30",

pages = "873--874",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

number = "Suppl. 5",

note = "44th Congress of the European Society for Medical Oncology, ESMO ; Conference date: 27-09-2019 Through 01-10-2019",

}

Cho, BC, Kato, K, Takahashi, M, Okada, M, Lin, C-Y, Chin, K, Kadowaki, S, Ahn, M-J, Hamamoto, Y, Doki, Y, Yen, C-C, Kubota, Y, Kim, S-B, Hsu, C-H, Holtved, E, Xynos, I, Kodani, M & Kitagawa, Y 2019, 'Nivolumab versus chemotherapy in advanced esophageal squamous cell carcinoma (ESCC): The phase III ATTRACTION-3 study', Annals of Oncology, bind 30, nr. Suppl. 5, LBA11, s. 873-874. https://doi.org/10.1093/annonc/mdz394.028

TY - ABST

T1 - Nivolumab versus chemotherapy in advanced esophageal squamous cell carcinoma (ESCC): The phase III ATTRACTION-3 study

AU - Cho, B. C.

AU - Kato, K.

AU - Takahashi, M.

AU - Okada, M.

AU - Lin, C-Y.

AU - Chin, K.

AU - Kadowaki, S.

AU - Ahn, M-J.

AU - Hamamoto, Y.

AU - Doki, Y.

AU - Yen, C-C.

AU - Kubota, Y.

AU - Kim, S-B.

AU - Hsu, C-H.

AU - Holtved, E.

AU - Xynos, I.

AU - Kodani, M.

AU - Kitagawa, Y.

PY - 2019/10

Y1 - 2019/10

U2 - 10.1093/annonc/mdz394.028

DO - 10.1093/annonc/mdz394.028

M3 - Conference abstract in journal

SN - 0923-7534

VL - 30

SP - 873

EP - 874

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl. 5

M1 - LBA11

T2 - 44th Congress of the European Society for Medical Oncology

Y2 - 27 September 2019 through 1 October 2019

ER -